Jasper Therapeutics, Inc.
JSPR
$4.87
$0.020.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 21.29M | 20.42M | 18.80M | 17.88M | 17.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 82.97M | 76.24M | 68.68M | 68.15M | 69.99M |
| Operating Income | -82.97M | -76.24M | -68.68M | -68.15M | -69.99M |
| Income Before Tax | -78.78M | -71.27M | -63.53M | -62.44M | -63.93M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -78.78 | -71.27 | -63.53 | -62.44 | -63.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -78.78M | -71.27M | -63.53M | -62.44M | -63.93M |
| EBIT | -82.97M | -76.24M | -68.68M | -68.15M | -69.99M |
| EBITDA | -81.61M | -74.87M | -67.27M | -67.01M | -68.86M |
| EPS Basic | -5.25 | -4.87 | -4.75 | -5.10 | -5.60 |
| Normalized Basic EPS | -3.28 | -3.04 | -2.97 | -3.21 | -3.55 |
| EPS Diluted | -5.25 | -4.87 | -4.75 | -5.10 | -5.60 |
| Normalized Diluted EPS | -3.28 | -3.04 | -2.97 | -3.21 | -3.55 |
| Average Basic Shares Outstanding | 60.02M | 58.33M | 54.37M | 50.34M | 46.27M |
| Average Diluted Shares Outstanding | 60.02M | 58.33M | 54.37M | 50.34M | 46.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |